Related Experiment Video
Updated: Jul 27, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study
Tao Wei1, Zhanfang Zhu2, Lin Liu1
1Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China.
Insights
Mendelian randomization revealed causal links between specific cytokines and cardiovascular diseases like coronary artery disease and heart failure. These findings suggest novel therapeutic targets for preventing and treating cardiovascular conditions.
Area of Science:
- Immunology
- Genetics
- Cardiovascular Medicine
Background:
- Circulating cytokines are linked to cardiovascular disease (CVD), but causality remains unclear.
- Bias may confound observational associations between cytokines and CVD.
- Mendelian randomization (MR) is used to investigate causal relationships.
Purpose of the Study:
- To systematically investigate the causal effects of circulating cytokine levels on CVD development using MR.
- To determine if genetic predisposition to cytokine levels causally influences CVD risk.
Main Methods:
- Leveraged genome-wide association study (GWAS) summary statistics for 47 cytokines and four CVD types.
- Employed a two-sample MR design using cis-quantitative trait loci (cis-QTL) as instrumental variables.
- Conducted comprehensive sensitivity analyses to ensure result robustness.
Main Results:
- Identified causal effects of IL-1ra, MCSF, SeSelectin, and SCF on coronary artery disease (CAD) risk.
- Found causal links between IL-2ra and IP-10 with heart failure (HF), and MCP-3 and SeSelectin with atrial fibrillation (AF).
- cis-expression QTL (cis-eQTL) analysis revealed additional associations for CAD, HF, and AF, with no significant findings for stroke.
Conclusions:
- Provides evidence that genetic predisposition to certain cytokine levels causally affects specific CVD development.
- Highlights potential novel therapeutic strategies targeting cytokines for CVD prevention and treatment.
Background:
Epidemiological studies have linked various circulating cytokines to cardiovascular disease (CVD), which however remains uncertain whether these relationships represent causality or are due to bias. To address this question, we conducted a Mendelian randomization (MR) analysis to systematically investigate the causal effects of circulating cytokine levels on CVD development.
Methods:
This study leveraged the summary statistic from respective genome-wide association study (GWAS) of 47 cytokines and four types of CVD. The cis-quantitative trait locus (cis-QTL) definition, derived from a GWAS meta-analysis comprising 31,112 participants of European descent, served as instruments for cytokines. A two-sample MR design was employed, followed by comprehensive sensitivity analyses to validate the robustness of results.
Results:
The results of inverse-variance weighted method using cis-protein QTL (cis-pQTL) instruments, showed the causal effects of four cytokines (i.e., IL-1ra, MCSF, SeSelectin, SCF) on the risk of coronary artery disease (CAD). We also identified causal relationships between two cytokines (i.e., IL-2ra, IP-10) and heart failure (HF), as well as two cytokines (i.e., MCP-3, SeSelectin) and atrial fibrillation (AF), after controlling for false discovery rate (FDR). The use of cis-expression QTL (cis-eQTL) revealed additional causal associations between IL-1a, MIF and CAD, between IL-6, MIF, and HF, as well as between FGFBasic and AF. No significant sign was survived for stroke with FDR applied. Results were largely consistent across sensitivity analyses.
Conclusion:
The present study provides supportive evidence that genetic predisposition to levels of certain cytokines causally affects the development of specific type of CVD. These findings have important implications for the creation of novel therapeutic strategies targeting these cytokines as a means of preventing and treating CVD.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
11:00Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
Published on: November 9, 2017
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
The JAK-STAT Signaling Pathway
Coronary Artery Disease II: Pathophysiology